These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21875955)

  • 1. Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.
    Viatour P; Ehmer U; Saddic LA; Dorrell C; Andersen JB; Lin C; Zmoos AF; Mazur PK; Schaffer BE; Ostermeier A; Vogel H; Sylvester KG; Thorgeirsson SS; Grompe M; Sage J
    J Exp Med; 2011 Sep; 208(10):1963-76. PubMed ID: 21875955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
    Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
    Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of RB transcription in vivo by RB family members.
    Burkhart DL; Ngai LK; Roake CM; Viatour P; Thangavel C; Ho VM; Knudsen ES; Sage J
    Mol Cell Biol; 2010 Apr; 30(7):1729-45. PubMed ID: 20100864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.
    Villanueva A; Alsinet C; Yanger K; Hoshida Y; Zong Y; Toffanin S; Rodriguez-Carunchio L; Solé M; Thung S; Stanger BZ; Llovet JM
    Gastroenterology; 2012 Dec; 143(6):1660-1669.e7. PubMed ID: 22974708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
    Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
    Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma.
    Zhang W; Xie HY; Ding SM; Xing CY; Chen A; Lai MC; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):289-96. PubMed ID: 27298105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensation by tumor suppressor genes during retinal development in mice and humans.
    Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA
    BMC Biol; 2006 May; 4():14. PubMed ID: 16672052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Retinoblastoma pathway regulates stem cell proliferation in freshwater planarians.
    Zhu SJ; Pearson BJ
    Dev Biol; 2013 Jan; 373(2):442-52. PubMed ID: 23123964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.
    Sengupta S; Henry RW
    Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer.
    Huntington JT; Tang X; Kent LN; Schmidt CR; Leone G
    J Cell Physiol; 2016 Jul; 231(7):1438-49. PubMed ID: 26566968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
    BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
    McClellan KA; Vanderluit JL; Julian LM; Andrusiak MG; Dugal-Tessier D; Park DS; Slack RS
    Mol Cell Biol; 2009 Sep; 29(17):4701-13. PubMed ID: 19564414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma protein potentiates the innate immune response in hepatocytes: significance for hepatocellular carcinoma.
    Hutcheson J; Bourgo RJ; Balaji U; Ertel A; Witkiewicz AK; Knudsen ES
    Hepatology; 2014 Oct; 60(4):1231-40. PubMed ID: 24824777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RB/E2F pathway and regulation of RNA processing.
    Ahlander J; Bosco G
    Biochem Biophys Res Commun; 2009 Jul; 384(3):280-3. PubMed ID: 19401190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma.
    Saddic LA; Wirt S; Vogel H; Felsher DW; Sage J
    PLoS One; 2011 May; 6(5):e19758. PubMed ID: 21573126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.
    Stengel KR; Thangavel C; Solomon DA; Angus SP; Zheng Y; Knudsen ES
    J Biol Chem; 2009 Jul; 284(29):19265-71. PubMed ID: 19279001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.
    Ma L; Dong P; Liu L; Gao Q; Duan M; Zhang S; Chen S; Xue R; Wang X
    Biochem Biophys Res Commun; 2016 Apr; 473(2):503-10. PubMed ID: 27003260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
    Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
    Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.